AHC Media - Continuing Medical Education Publishing

The most award winning

healthcare information source.

TRUSTED FOR FOUR DECADES.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » CDC: At-Risk Flu Patients Should Receive Antivirals

    CDC: At-Risk Flu Patients Should Receive Antivirals

    All hospitalized patients with suspected or confirmed flu

    February 1, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    HHS plan for hospitals to stockpile pandemic flu antivirals draws fire

    CDC issues antiviral priorities for flu season

    CDC: Add HCW flu shots to patient safety program

    Related Products

    Safe Injection Practices & IV Push Guidelines: Compliance with CDC & CMS CoPs

    Crosswalk to Advance Directives: What Healthcare Providers Should Know

    Patient Safety & Risk Management Update 2017

    Related Events

    Roadmap for Advancing Patient Safety

    TJC Sentinel Event Policy, Patient Safety Systems, and CMS RCA Requirements

    CMS to Hospitals: How to Overcome the QAPI Worksheet and Standards

    Neuraminidase inhibitor (NAI) antiviral medications should be brought to bear early and often to stave off severe and fatal flu infections due to a vaccine mismatch this season, the CDC recommends.1

    “The CDC recommends antiviral medications for treatment of influenza as an important adjunct to annual influenza vaccination,” the agency stated in its health advisory. “Treatment with neuraminidase inhibitors has been shown to have clinical and public health benefit in reducing illness and severe outcomes of influenza based on evidence from randomized controlled trials, meta-analyses of randomized controlled trials, and observational studies during past influenza seasons and during the 2009 H1N1 pandemic.… All hospitalized, severely ill, and high-risk patients with suspected or confirmed influenza should be treated with antivirals.”

    Some of the key CDC recommendations are summarized as follows.

    Any patient with suspected or confirmed influenza in the following categories should be treated as soon as possible with a neuraminidase inhibitor:

    • a patient who has severe, complicated, or progressive illness — this may include outpatients with severe or prolonged progressive symptoms or who develop complications such as pneumonia but are not hospitalized;
    • a patient who is at higher risk for influenza complications but not hospitalized. Patients in this group include children younger than two years;
    • people with chronic pulmonary problems, including asthma; cardiovascular, renal, hepatic, hematological, and metabolic disorders, or neurologic and neurodevelopment conditions such as stroke, intellectual disability, moderate to severe developmental delay, muscular dystrophy, or spinal cord injury;
    • people with immunosuppression, including that caused by medications or by HIV infection;
    • women who are pregnant or postpartum (within two weeks after delivery);
    • people aged younger than 19 years who are receiving long-term aspirin therapy;
    • American Indians and Alaska Natives;
    • people with extreme obesity (i.e., body mass index equal to or greater than 40);
    • residents of nursing homes and other chronic care facilities.

    REFERENCE

    1. CDC. Seasonal Influenza A(H3N2) Activity and Antiviral Treatment of Patients with Influenza. Health Alert Network. Dec. 27, 2017. Available at: http://bit.ly/2E9AstE.

    Post a comment to this article

    Report Abusive Comment

    www.ahcmedia.com

    Hospital Infection Control & Prevention

    View PDF
    Hospital Infection Control & Prevention (Vol. 45, No. 2) February 2018
    February 1, 2018

    Table Of Contents

    Severe Flu Season a Call to Action for Infection Preventionists

    CDC: At-Risk Flu Patients Should Receive Antivirals

    Zika Virus: Not Gone, Certainly Not Forgotten

    Changing Human Behavior on Antibiotic Stewardship

    NIH Approves Research to Enhance Pandemic Pathogens

    Pediatricians Call for Mandated Flu Shots for Clinic Staff

    CDC: No Ban on Politically Charged Words

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Senior Writer Gary Evans, Editor Jesse Saffron, Editor Jill Drachenberg, Nurse Planner Patti Grant, RN, BSN, MS, CIC, Peer Reviewer Patrick Joseph, MD, and Editorial Group Manager Terrey L. Hatcher report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Group & Site
      Licenses
    • Upcoming Live Webinars
    • On-Demand Webinars
    • State CME/CE
      Requirements

    Webinars And Events

    EMTALA Series

    Apr 24 2018, 3:30pm EDT
    Live Webinar

    Preventing Medication Errors: 60+ Tips to Implement Today

    Apr 25 2018, 3:30pm EDT
    Live Webinar

    Pain Management 101: CMS Opioid, IV Medication, and Blood Transfusion Guidelines

    May 1 2018, 3:30pm EDT
    Live Webinar
    View All Events

    Free Email Newsletters

    • Accreditation Council for Continuing Medical Education
    • American Nurses Credentialing Center
    • American College of Emergency Physician
    • American Board of Internal Medicine: Maintenance of Certification
    • California Board of Registered Nursing
    • Commission for Case Manager Certification
    • American Academy of Pediatrics
    • American Osteopathic Association
    • Stand Up for Kids
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
      • Libraries
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Live Webinars
      • On-Demand Webinars
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    AHC Media - Continuing Medical Education Publishing

    The most award winning

    healthcare information source.

    TRUSTED FOR FOUR DECADES.

    Customer Service

    Customer.Service@AHCMedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ahcmedia_ar@reliaslearning.com

    Mailing Address

    • 111 Corning Road, Suite 250
      Cary, NC 27518
      USA

    © 2018 Relias. All rights reserved.

    Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    Design, CMS, Hosting & Web Development :: ePublishing